Expansion opportunities Leverage Sidekick Health’s global market presence, US-focused activity, and recent MSK and obesity collaboration initiatives to position integrated digital health solutions with payers, pharma partners, and healthcare providers seeking scalable therapeutic digital programs.

Strategic partnerships Target health insurers and pharmaceutical companies already collaborating with Sidekick, and identify opportunities to co-create or co-brand digital therapeutics (for obesity, MSK, and prescribable therapies) to expand coverage and reimbursement potential.

Therapeutic breadth Capitalize on the zanadio obesity platform and Sidekick Rx for prescribable therapeutics to upsell integrated digital care pathways to clinics treating obesity, diabetes, and related comorbidities, aligning with value-based care trends.

Clinical integration Promote synergies with autoinjector and device partners (such as Ypsomed) to create end-to-end digital-physical treatment solutions, enhancing adherence programs and expanding wearable/medical device integrations.

Innovation signals Monitor and engage around recent product launches (MSK program, pain management, and VCT offering) as proof points for innovative digital health capabilities, using these milestones to approach multi-stakeholder buyers seeking novel patient support tools.